...
....
Pharmaceutical
Biotechnology

> See specialized channels
Medical Devices & Diagnostics
> See specialized channels
Industrial
Biotechnology
> See specialized channels


  Join us

  Follow us on Twitter   Join our LinkedIn Group   Our Blog

Biotech News App
Provides access to the latest biotech press releases ...more

Android_Logo App Store RIM_Logo_small

Media Partnership:
Want to have your RSS feed integrated on our website? Contact us
RSS Feeds RSS Feeds
JoomlaWatch Stats 1.2.9 by Matej Koval
For Editors
Sign up for press releases
For Companies
Sign up for our newsletter


All Biotech Press Releases



> RedHill Biopharma Announces First Dosing in RHB-105 Supportive PK Studies Ahead of Confirmatory Phase III Study for H. pylori Infection
01/10/17
> Orchard Therapeutics Ltd. Announces a Manufacturing Alliance with PharmaCell B.V.
01/09/17
> leon-nanodrugs GmbH Appoints Pharma Expert Michael Mehler as Chief Executive Officer
01/09/17
> Hookipa Biotech Announces Publication in Clinical and Vaccine Immunology Highlighting Vaxwave® as an Effective Viral Vector for Vaccination against Congenital Cytomegalovirus Infections
01/09/17
> RedHill Biopharma Announces YELIVA® (ABC294640) Abstract Presentation at the 2017 Cholangiocarcinoma Foundation Annual Conference
01/06/17
> HUB and Dutch Health Insurance Companies to Validate Use of Organoids for Cystic Fibrosis
01/06/17
> Xigen’s Brimapitide, an Innovative JNK Inhibitor, Delivers Positive Phase II Results in Inflammatory Eye Disease
01/05/17
> RedHill Biopharma Announces Exclusive U.S. Co-Promotion Agreement with Concordia for GI Drug Donnatal®
01/03/17
> New Data Shows that MammaPrint® Substantially Impacts How Breast Cancer Patients in Germany are Treated
12/21/16
> bluebird bio and apceth Biopharma Establish Commercial Drug Product Manufacturing Agreement
12/15/16
> RedHill Biopharma and IntelGenx Announce Definitive Agreement for Commercialization of RIZAPORT® for Migraines with Pharmatronic Co. in South Korea
12/14/16
> Three New Studies Presented at San Antonio Breast Cancer Symposium Further Demonstrate Value of MammaPrint® and BluePrint® in Individualizing Treatment for Breast Cancer Patients
12/14/16
> Acousia Therapeutics Receives EUR 2.5 Million to Develop Innovative Therapy to Treat and Prevent Sensorineural Hearing Loss
12/14/16
> Vetter's Skokie Site Successfully Manufactures Batches on New Clinical Syringe Filling Line
12/13/16
> RedHill Biopharma Announces Positive and Unanimous DSMB Recommendation for Continuation of Phase III Study with RHB-104 for Crohn's Disease
12/13/16
> RedHill Biopharma Announces Phase IIa 48-Week Final Results Further Supporting Potential of RHB-104 in Multiple Sclerosis
12/12/16
> New Flash Cartridges for Peptide Purification from Biotage
12/07/16
> LifeCodexx Receives CE Mark for its Novel NIPT Solution Based On Methylation-Specific Quantitative PCR
12/07/16
> leon-nanodrugs Partners with Instillo for GMP Production of a MicroJet Reactor (MJR®) Based Formulation of a Generic Oncology Supportive Product
12/07/16
> Neurimmune and TVM Capital Life Science Announce Creation of AL-S Pharma to Develop Innovative Therapy for Patients with ALS
12/07/16
> Pfizer Ventures and TVM Life Science Ventures VII Announce Additional Investment in Ixchelsis Ltd.
12/05/16
> Agendia’s MammaPrint® and BluePrint® Tests Highlighted in Multiple Presentations at the 2016 San Antonio Breast Cancer Symposium, Adding Further Clinical Utility
12/02/16
> New Vetter Data Processing Center is Officially Certified
11/30/16
> Orchard Therapeutics Announces Strategic Alliance with Oxford BioMedica
11/29/16
> Orchard Therapeutics and UCLA Receive USD20 Million in Latest Round of Funding from California’s Stem Cell Agency
11/23/16
> RedHill Biopharma Announces YELIVA™ (ABC294640) Poster Presentation at the 2016 EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium
11/21/16
> Independent Clinical Study Shows Adherium’s Smartinhaler™ Dramatically Improves Clinical Outcomes and Medication Adherence in Children with Asthma
11/17/16
> Zytoprotec Phase II Peritoneal Dialysis Study: Last Patient Out
11/14/16
> Prospective Clinical Follow-Up Study with Over 2,200 Patients Confirms High Test Accuracy of Prenatest® for Fetal Trisomies
11/14/16
> Xellia Pharmaceuticals Commences Packaging and Distribution Operations at Cleveland Site after Successful FDA Inspection
11/14/16
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Page 3 of 48